Projects
Case content is anonymized by default, emphasizing challenge, technical response, and project outcome without exposing sensitive customer information.
Challenge
A discovery team needed a non-commercial morpholino monomer intermediate with tight timeline pressure.
Solution
The route was redesigned around accessible raw materials and a controlled protection strategy.
Result
First qualified batch delivered for PMO research and follow-up analog expansion.
Challenge
A formulation group required multiple lipid analogs for LNP structure activity screening.
Solution
Parallel synthetic routes were planned to vary linker, tail, and headgroup motifs efficiently.
Result
A focused analog set supported formulation screening and next-round lead selection.
Challenge
A medicinal chemistry program required a functionalized E3 ligand intermediate that was not available commercially.
Solution
Selective functionalization and purification conditions were optimized for reliable repeat batches.
Result
The intermediate enabled linker diversification and confidential SAR development.